An emerging role of mast cells in cerebral ischemia and hemorrhage

References

• Ayata C, Ropper A. Ischaemic brain oedema. J Clin Neurosci. 2002; 9: 113–24
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008; 359: 1317–29
   PubMed Web of Science ®Google Scholar
• Grines CL, Serruys P, O'Neill WW. Fibrinolytic therapy: is it a treatment of the past?. Circulation. 2003; 107: 2538–42
   Google Scholar
• Han S, Chaya C, Hoo GW. Thrombolytic therapy for massive pulmonary embolism in a patient with a known intracranial tumor. J Intensive Care Med. 2006; 21: 240–5
   Google Scholar
• Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008; 358: 2127–37
   PubMed Web of Science ®Google Scholar
• Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005; 365: 387–97
   PubMed Web of Science ®Google Scholar
• Nilsson OG, Lindgren A, Brandt L, Saveland H. Prediction of death in patients with primary intracerebral hemorrhage: a prospective study of a defined population. J Neurosurg. 2002; 97: 531–6
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Algra A, Franke CL, Koudstaal PJ, Rinkel GJ. Long-term prognosis after recovery from primary intracerebral hemorrhage. Neurology. 2002; 59: 205–9
   PubMed Web of Science ®Google Scholar
• Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg. 1996; 84: 91–6
   PubMed Web of Science ®Google Scholar
• Lee KR, Betz AL, Kim S, Keep RF, Hoff JT. The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir. 1996; 138: 396–401
   PubMed Web of Science ®Google Scholar
• Xi GH, Hua Y, Bhasin RR, Ennis SR, Keep RF, Hoff JT. Mechanisms of edema formation after intracerebral hemorrhage: Effects of extravasated red blood cells on blood flow and blood-brain barrier integrity. Stroke. 2001; 32: 2932–8
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Ali Z, Suri MF, Shuaib A, Baker G, Todd K, et al. Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study. Crit Care Med. 2003; 31: 1482–9
   PubMed Web of Science ®Google Scholar
• Power C, Henry S, del Bigio MR, Larsen PH, Corbett D, Imai Y, et al. Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol. 2003; 53: 731–42
   PubMed Web of Science ®Google Scholar
• Vannucci RC. Hypoxic-ischemic encephalopathy. Am J Perinatol. 2000; 17: 113–20
   PubMed Web of Science ®Google Scholar
• Galli SJ. Mast cells and basophils. Curr Opin Hematol. 2000; 7: 32–9
   PubMed Web of Science ®Google Scholar
• Costa JJ, Weller PF, Galli SJ. The cells of the allergic response: mast cells, basophils, and eosinophils. JAMA. 1997; 278: 1815–22
   PubMed Web of Science ®Google Scholar
• Dvorak AM. Biochemical contents of granules and lipid bodies – two distinctive organelles found in basophils and mast cells. Basophil and mast cell degranulation and recovery, JR Harris. Plenum Press, New York 1991; 4: 27–65
   Google Scholar
• Galli SJ. New insights into ‘the riddle of the mast cells’: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest. 1990; 62: 5–33
   PubMed Web of Science ®Google Scholar
• Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol. 1989; 7: 59–76
   PubMed Web of Science ®Google Scholar
• Rodewald HR, Dessing M, Dvorak AM, Galli SJ. Identification of a committed precursor for the mast cell lineage. Science. 1996; 271: 818–22
   PubMed Web of Science ®Google Scholar
• Kitamura Y, Go S, Hatanaka K. Decrease of mast-cells in W/Wv mice and their increase by bone-marrow transplantation. Blood. 1978; 52: 447–52
   PubMed Web of Science ®Google Scholar
• Galli SJ. New concepts about the mast cell. N Engl J Med. 1993; 328: 257–65
   PubMed Web of Science ®Google Scholar
• Mekori YA, Oh CK, Metcalfe DD. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J Immunol. 1993; 151: 3775–84
   PubMed Web of Science ®Google Scholar
• Horigome K, Bullock ED, Johnson EM, Jr. Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. J Biol Chem. 1994; 269: 2695–702
   PubMed Web of Science ®Google Scholar
• Shanas U, Bhasin R, Sutherland AK, Silverman AJ, Silver R. Brain mast cells lack the c-kit receptor: immunocytochemical evidence. J Neuroimmunol. 1998; 90: 207–11
   PubMed Web of Science ®Google Scholar
• Leon A, Buriani A, Dal Toso R, Fabris M, Romanello S, Aloe L, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A. 1994; 91: 3739–43
   PubMed Web of Science ®Google Scholar
• Theoharides TC. Mast cells: the immune gate to the brain. Life Sci. 1990; 46: 607–17
   PubMed Web of Science ®Google Scholar
• Silver R, Silverman AJ, Vitkovic L, Lederhendler II. Mast cells in the brain: evidence and functional significance. Trends Neurosci. 1996; 19: 25–31
   PubMed Web of Science ®Google Scholar
• Pang X, Letourneau R, Rozniecki JJ, Wang L, Theoharides TC. Definitive characterization of rat hypothalamic mast cells. Neuroscience. 1996; 73: 889–902
   PubMed Web of Science ®Google Scholar
• Cocchiara R, Bongiovanni A, Albeggiani G, Azzolina A, Geraci D. Evidence that brain mast cells can modulate neuroinflammatory responses by tumour necrosis factor-alpha production. Neuroreport. 1998; 9: 95–8
   Google Scholar
• Dimitriadou V, Lambracht-Hall M, Reichler J, Theoharides TC. Histochemical and ultrastructural characteristics of rat brain perivascular mast cells stimulated with compound 48/80 and carbachol. Neuroscience. 1990; 39: 209–24
   PubMed Web of Science ®Google Scholar
• Goldschmidt RC, Hough LB, Glick SD, Padawer J. Mast cells in rat thalamus: nuclear localization, sex difference and left-right asymmetry. Brain Res. 1984; 323: 209–17
   PubMed Web of Science ®Google Scholar
• Dropp, JJ. Mast cells in mammalian brain. Acta Anat. 1976:1–21.
   Google Scholar
• Ibrahim MZ. The mast cells of the mammalian central nervous system. Part I. Morphology, distribution and histochemistry. J Neurol Sci. 1974; 21: 431–78
   Google Scholar
• Holgate ST, Robinson C, Church MK. Mediators of immediate hypersensitivity. Allergy: Principles and practice, E Middleton, Jr, CE Reed, EF Ellis, NF Adkinson, Jr, JW Yuninger. Mosby, St Louis 1988; 135–63
   Google Scholar
• Johnson D, Krenger W. Interactions of mast cells with the nervous system—recent advances. Neurochem Res. 1992; 9: 939–51
   Google Scholar
• Theoharides TC, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev. 2007; 217: 65–78
   PubMed Web of Science ®Google Scholar
• Theoharides TC, Bondy PK, Tsakalos ND, Askenase PW. Differential release of serotonin and histamine from mast cells. Nature. 1982; 297: 229–31
   PubMed Web of Science ®Google Scholar
• Dvorak AM, McLeod RS, Onderdonk A, Monahan-Earley RA, Cullen JB, Antonioli DA, et al. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int Arch Allergy Immunol. 1992; 99: 74–83
   PubMed Web of Science ®Google Scholar
• Letourneau R, Rozniecki JJ, Dimitriadou V, Theoharides TC. Ultrastructural evidence of brain mast cell activation without degranulation in monkey experimental allergic encephalomyelitis. J Neuroimmunol. 2003; 145: 18–26
   Google Scholar
• Neuman J. Ueber das Vorkommen der sogenannten ‘mastzellen’ bei pathologischen Veraenderungen des Gehirns. Arch Pathol Anat Physiol Virchows. 1890; 122: 378
   Google Scholar
• Manning KA, Pienkowski TP, Uhlrich DJ. Histaminergic and non-histamine-immunoreactive mast cells within the cat lateral geniculate complex examined with light and electron microscopy. Neuroscience. 1994; 63: 191–206
   Google Scholar
• Lambracht-Hall M, Dimitriadou V, Theoharides TC. Migration of mast cells in the developing rat brain. Brain Res Dev Brain Res. 1990; 56: 151–9
   PubMedGoogle Scholar
• Khalil M, Ronda J, Weintraub M, Jain K, Silver R, Silverman AJ. Brain mast cell relationship to neurovasculature during development. Brain Res. 2007; 1171: 18–29
   Google Scholar
• Florenzano F, Bentivoglio M. Degranulation, density, and distribution of mast cells in the rat thalamus: a light and electron microscopic study in basal conditions and after intracerebroventricular administration of nerve growth factor. J Comp Neurol. 2000; 424: 651–69
   PubMed Web of Science ®Google Scholar
• Hough L. Cellular localization and possible functions for brain histamine: recent progress. Prog Neurobiol. 1988; 30: 469–505
   PubMed Web of Science ®Google Scholar
• Silverman AJ, Sutherland AK, Wilhelm M, Silver R. Mast cells migrate from blood to brain. J Neurosci. 2000; 20: 401–8
   PubMed Web of Science ®Google Scholar
• Karjalainen-Lindsberg, M-L, Tatlisumak, T, Lindsberg, PJ. Mast cells in ischemic rat brain. Society for Neuroscience, Poster presentation, San Diego. 2001:Abstract No:330.11.
   Google Scholar
• Strbian D, Tatlisumak T, Karjalainen-Lindsberg M-L, Lindsberg PJ. Mast cells regulate ischemic brain edema (abstract). J Cereb Blood Flow Metab. 2003; 23(Suppl 1)166
   Google Scholar
• Hu W, Xu L, Pan J, Zheng X, Chen Z. Effect of cerebral ischemia on brain mast cells in rats. Brain Res. 2004; 1019: 275–80
   PubMed Web of Science ®Google Scholar
• Hu W, Shen Y, Fu Q, Dai H, Tu H, Wei E, et al. Effect of oxygen-glucose deprivation on degranulation and histamine release of mast cells. Cell Tissue Res. 2005; 322: 437–41
   Google Scholar
• Strbian D, Karjalainen-Lindsberg ML, Kovanen PT, Tatlisumak T, Lindsberg PJ. Mast cell stabilization reduces hemorrhage formation and mortality after administration of thrombolytics in experimental ischemic stroke. Circulation. 2007; 116: 411–8
   PubMed Web of Science ®Google Scholar
• Skaper SD, Facci L, Kee WJ, Strijbos PJ. Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurones: a possible role for mast cells. J Neurochem. 2001; 76: 47–55
   Google Scholar
• Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol. 1998; 44: 665–75
   PubMed Web of Science ®Google Scholar
• Dommergues MA, Patkai J, Renauld JC, Evrard P, Gressens P. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol. 2000; 47: 54–63
   PubMed Web of Science ®Google Scholar
• Patkai J, Mesples B, Dommergues MA, Fromont G, Thornton EM, Renauld JC, et al. Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain. Pediatr Res. 2001; 50: 222–30
   PubMed Web of Science ®Google Scholar
• Matsuzawa S, Sakashita K, Kinoshita T, Ito S, Yamashita T, Koike K. IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor. J Immunol. 2003; 170: 3461–7
   PubMed Web of Science ®Google Scholar
• Gressens P, Marret S, Hill JM, Brenneman DE, Gozes I, Fridkin M, et al. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J Clin Invest. 1997; 100: 390–7
   PubMed Web of Science ®Google Scholar
• Marret S, Mukendi R, Gadisseux JF, Gressens P, Evrard P. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol. 1995; 54: 358–70
   Google Scholar
• Jin Y, Silverman AJ, Vannucci SJ. Mast cell stabilization limits hypoxic-ischemic brain damage in the immature rat. Dev Neurosci. 2007; 29: 373–84
   PubMed Web of Science ®Google Scholar
• Biran V, Cochois V, Karroubi A, Arrang JM, Charriaut-Marlangue C, Heron A. Stroke induces histamine accumulation and mast cell degranulation in the neonatal rat brain. Brain Pathol. 2008; 18: 1–9
   Google Scholar
• Hedtjarn M, Mallard C, Hagberg H. Inflammatory gene profiling in the developing mouse brain after hypoxia-ischemia. J Cereb Blood Flow Metab. 2004; 24: 1333–51
   PubMedGoogle Scholar
• Strbian D, Karjalainen-Lindsberg ML, Tatlisumak T, Lindsberg PJ. Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J Cereb Blood Flow Metab. 2006; 26: 605–12
   PubMed Web of Science ®Google Scholar
• Joo F, Tosaki A, Olah Z, Koltai M. Inhibition by H-7 of the protein kinase C prevents formation of brain edema in Sprague-Dawley CFY rats. Brain Res. 1989; 490: 141–3
   PubMed Web of Science ®Google Scholar
• Tosaki A, Szerdahelyi P, Joo F. Treatment with ranitidine of ischemic brain edema. Eur J Pharmacol. 1994; 264: 455–8
   Google Scholar
• Hickey WF. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1991; 1: 97–105
   PubMed Web of Science ®Google Scholar
• Theoharides TC, Dimitriadou V, Letourneau R, Rozniecki JJ, Vliagoftis H, Boucher W. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain myelin changes resembling early stages of demyelination. Neuroscience. 1993; 57: 861–71
   PubMedGoogle Scholar
• Gaboury JP, Johnston B, Niu XF, Kubes P. Mechanisms underlying acute mast cell-induced leukocyte rolling and adhesion in vivo. J Immunol. 1995; 154: 804–13
   Google Scholar
• Kubes P, Gaboury JP. Rapid mast cell activation causes leukocyte-dependent and -independent permeability alterations. Am J Physiol. 1996; 271: H2438–46
   Google Scholar
• Kubes P, Granger DN. Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res. 1996; 32: 699–708
   PubMedGoogle Scholar
• Gilles S, Zahler S, Welsch U, Sommerhoff CP, Becker BF. Release of TNF-alpha during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc Res. 2003; 60: 608–16
   PubMed Web of Science ®Google Scholar
• Singh M, Saini HK. Resident cardiac mast cells and ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther. 2003; 8: 135–48
   Google Scholar
• Frangogiannis NG, Lindsey ML, Michael LH, Youker KA, Bressler RB, Mendoza LH, et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation. 1998; 98: 699–710
   PubMed Web of Science ®Google Scholar
• Horwitz LD, Kaufman D, Kong Y. An antibody to leukocyte integrins attenuates coronary vascular injury due to ischemia and reperfusion in dogs. Am J Physiol. 1997; 272: H618–24
   Google Scholar
• Lefer DJ, Flynn DM, Buda AJ. Effects of a monoclonal antibody directed against P-selectin after myocardial ischemia and reperfusion. Am J Physiol. 1996; 270: H88–98
   PubMed Web of Science ®Google Scholar
• Morikawa T, Imanishi M, Suzuki H, Okada N, Okumura M, Konishi Y, et al. Mast cell chymase in the ischemic kidney of severe unilateral renovascular hypertension. Am J Kidney Dis 2005; 45: e45–50
   Google Scholar
• Kalia N, Brown NJ, Wood RF, Pockley AG. Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury. J Gastroenterol Hepatol. 2005; 20: 1032–8
   Google Scholar
• Szalay L, Kaszaki J, Nagy S, Boros M. Endothelin-1 induces mucosal mast cell degranulation in the rat small intestine. Life Sci. 2000; 67: 1947–58
   Google Scholar
• Boros M, Kaszaki J, Ordogh B, Nagy S. Mast cell degranulation prior to ischemia decreases ischemia-reperfusion injury in the canine small intestine. Inflamm Res. 1999; 48: 193–8
   Google Scholar
• Kanwar S, Kubes P. Ischemia/reperfusion-induced granulocyte influx is a multistep process mediated by mast cells. Microcirculation. 1994; 1: 175–82
   PubMedGoogle Scholar
• Kurose I, Anderson DC, Miyasaka M, Tamatani T, Paulson JC, Todd RF, et al. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res. 1994; 74: 336–43
   PubMed Web of Science ®Google Scholar
• Abonia JP, Friend DS, Austen WG, Jr, Moore FD, Jr, Carroll MC, Chan R, et al. Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. J Immunol. 2005; 174: 7285–91
   PubMed Web of Science ®Google Scholar
• Mukundan C, Gurish MF, Austen KF, Hechtman HB, Friend DS. Mast cell mediation of muscle and pulmonary injury following hindlimb ischemia-reperfusion. J Histochem Cytochem. 2001; 49: 1055–6
   Google Scholar
• Korthuis RJ, Carden DL, Kvietys PR, Shepro D, Fuseler J. Phalloidin attenuates postischemic neutrophil infiltration and increased microvascular permeability. J Appl Physiol. 1991; 71: 1261–9
   Google Scholar
• Vural KM, Liao H, Oz MC, Pinsky DJ. Effects of mast cell membrane stabilizing agents in a rat lung ischemia-reperfusion model. Ann Thorac Surg. 2000; 69: 228–32
   Google Scholar
• Goldman G, Welbourn R, Klausner JM, Kobzik L, Valeri CR, Shepro D, et al. Mast cells and leukotrienes mediate neutrophil sequestration and lung edema after remote ischemia in rodents. Surgery. 1992; 112: 578–86
   PubMed Web of Science ®Google Scholar
• Dimitriadou V, Rouleau A, Tuong MD, Ligneau X, Newlands GF, Miller HR, et al. Rat cerebral mast cells undergo phenotypic changes during development. Brain Res Dev Brain Res. 1996; 97: 29–41
   Google Scholar
• Zhuang X, Silverman AJ, Silver R. Brain mast cell degranulation regulates blood-brain barrier. J Neurobiol. 1996; 31: 393–403
   Google Scholar
• Esposito P, Gheorghe D, Kandere K, Pang X, Connoly R, Jacobson S, et al. Acute stress increases permeability of the blood-brain barrier through activation of brain mast cells. Brain Res. 2001; 888: 117–27
   PubMed Web of Science ®Google Scholar
• Goodin DS, Ebers GC, Johnson KP, Rodriguez M, Sibley WA, Wolinsky JS. The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1999; 52: 1737–45
   PubMed Web of Science ®Google Scholar
• Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DP, et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain. 1990; 113(Pt 5)1477–89
   PubMedGoogle Scholar
• Hamann GF, Okada Y, Fitridge R, del Zoppo GJ. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke. 1995; 26: 2120–6
   PubMed Web of Science ®Google Scholar
• Tagaya M, Haring H-P, Stuiver I, Wagner S, Abumiya T, Lucero J, et al. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J Cereb Blood Flow Metab. 2001; 21: 835–46
   PubMed Web of Science ®Google Scholar
• Yong VW, Power C, Forsyth P, Edwards DR. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci. 2001; 2: 502–11
   PubMed Web of Science ®Google Scholar
• Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci. 2001; 21: 7724–32
   PubMed Web of Science ®Google Scholar
• Hamann GF, Okada Y, del Zoppo GJ. Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion. J Cereb Blood Flow Metab. 1996; 16: 1373–8
   PubMed Web of Science ®Google Scholar
• Heo JH, Lucero J, Abumiya T, Koziol JA, Copeland BR, del Zoppo GJ. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab. 1999; 19: 624–33
   PubMed Web of Science ®Google Scholar
• Sumii T, Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke. 2002; 33: 831–6
   PubMed Web of Science ®Google Scholar
• Lo EH, Wang X, Cuzner ML. Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases. J Neurosci Res. 2002; 69: 1–9
   PubMed Web of Science ®Google Scholar
• Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke. 1998; 29: 2189–95
   PubMed Web of Science ®Google Scholar
• Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007; 27: 697–709
   PubMed Web of Science ®Google Scholar
• Miller A, Ben-Yosef Y, Braker C, Shapiro S. Matrix metalloproteinases and their inhibitors in hypoxia/reoxygenation and stroke. Inflammation and stroke, GZ Feuerstein. Birkhäuser Verlag, Basel 2001; 275–85
   Google Scholar
• Morales CR, Pereyra LA, Toledo OM, Montes GS. Histochemical and morphological characterization of migrating mast cells in the bovine gallbladder epithelium. Histochemistry. 1980; 68: 159–68
   PubMedGoogle Scholar
• Zhang Y, Ramos BF, Jakschik BA. Mast cells enhance the antibody-mediated injury of skin basement membrane in mice. J Immunol. 1992; 149: 2482–7
   Google Scholar
• Metcalfe DD. Interaction of mast cells with extracellular matrix proteins. Int Arch Allergy Immunol. 1995; 107: 60–2
   Google Scholar
• Thompson HL, Thomas L, Metcalfe DD. Murine mast cells attach to and migrate on laminin-, fibronectin-, and matrigel-coated surfaces in response to Fc epsilon RI-mediated signals. Clin Exp Allergy. 1993; 23: 270–5
   PubMedGoogle Scholar
• Thompson HL, Burbelo PD, Yamada Y, Kleinman HK, Metcalfe DD. Identification of an amino acid sequence in the laminin A chain mediating mast cell attachment and spreading. Immunology. 1991; 72: 144–9
   Google Scholar
• Lehtonen-Smeds EM, Mäyränpää M, Lindsberg PJ, Soinne L, Saimanen E, Järvinen AA, et al. Carotid plaque mast cells associate with atherogenic serum lipids, high grade carotid stenosis and symptomatic carotid artery disease. Results from the helsinki carotid endarterectomy study. Cerebrovasc Dis. 2005; 19: 291–301
   PubMed Web of Science ®Google Scholar
• Mäyränpää MI, Heikkilä HM, Lindstedt KA, Walls AF, Kovanen PT. Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion. Coron Artery Dis. 2006; 17: 611–21
   Google Scholar
• Goldschmidt RC, Hough LB, Glick SD. Rat brain mast cells: contribution to brain histamine levels. J Neurochem. 1985; 44: 1943–7
   PubMed Web of Science ®Google Scholar
• Andriopoulou P, Navarro P, Zanetti A, Lampugnani MG, Dejana E. Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol. 1999; 19: 2286–97
   PubMed Web of Science ®Google Scholar
• Winter MC, Shasby SS, Ries DR, Shasby DM. Histamine selectively interrupts VE-cadherin adhesion independently of capacitive calcium entry. Am J Physiol Lung Cell Mol Physiol. 2004; 287: L816–23
   Google Scholar
• Itoh Y, Sendo T, Oishi R. Physiology and pathophysiology of proteinase-activated receptors (PARs): role of tryptase/PAR-2 in vascular endothelial barrier function. J Pharmacol Sci. 2005; 97: 14–9
   PubMed Web of Science ®Google Scholar
• Schechter NM, Brass LF, Lavker RM, Jensen PJ. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts. J Cell Physiol. 1998; 176: 365–73
   PubMed Web of Science ®Google Scholar
• Ebihara N, Funaki T, Murakami A, Takai S, Miyazaki M. Mast cell chymase decreases the barrier function and inhibits the migration of corneal epithelial cells. Curr Eye Res. 2005; 30: 1061–9
   PubMed Web of Science ®Google Scholar
• Saarinen J, Kalkkinen N, Welgus H, Kovanen P. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J Biol Chem. 1994; 269: 18134–40
   PubMed Web of Science ®Google Scholar
• Tetlow LC, Harper N, Dunningham T, Morris MA, Bertfield H, Woolley DE. Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro. Ann Rheum Dis. 1998; 57: 25–32
   Google Scholar
• Frank BT, Rossall JC, Caughey GH, Fang KC. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase. J Immunol. 2001; 166: 2783–92
   PubMed Web of Science ®Google Scholar
• Di Girolamo N, Indoh I, Jackson N, Wakefield D, McNeil HP, Yan W, et al. Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration. J Immunol. 2006; 177: 2638–50
   PubMed Web of Science ®Google Scholar
• Tchougounova E, Lundequist A, Fajardo I, Winberg JO, Abrink M, Pejler G. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem. 2005; 280: 9291–6
   PubMed Web of Science ®Google Scholar
• Lohi J, Harvima I, Keski-Oja J. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J Cell Biochem. 1992; 50: 337–49
   PubMed Web of Science ®Google Scholar
• Fang KC, Wolters PJ, Steinhoff M, Bidgol A, Blount JL, Caughey GH. Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF-beta. J Immunol. 1999; 162: 5528–35
   PubMed Web of Science ®Google Scholar
• Helske S, Syväranta S, Kupari M, Lappalainen J, Laine M, Lommi J, et al. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. Eur Heart J. 2006; 27: 1495–504
   PubMed Web of Science ®Google Scholar
• Fukuda S, Fini CA, Mabuchi T, Koziol JA, Eggleston LL, Jr, del Zoppo GJ. Focal cerebral ischemia induces active proteases that degrade microvascular matrix. Stroke. 2004; 35: 998–1004
   PubMed Web of Science ®Google Scholar
• Rosenberg GA, Estrada EY, Dencoff JE, Stetler-Stevenson WG. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res. 1995; 703: 151–5
   PubMed Web of Science ®Google Scholar
• Kim KS, Wass CA, Cross AS, Opal SM. Modulation of blood-brain barrier permeability by tumor necrosis factor and antibody to tumor necrosis factor in the rat. Lymphokine Cytokine Res. 1992; 11: 293–8
   PubMedGoogle Scholar
• Yamasaki Y, Suzuki T, Yamaya H, Matsuura N, Onodera H, Kogure K. Possible involvement of interleukin-1 in ischemic brain edema formation. Neurosci Lett. 1992; 142: 45–7
   PubMed Web of Science ®Google Scholar
• Stack MS, Johnson DA. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase). J Biol Chem. 1994; 269: 9416–9
   PubMed Web of Science ®Google Scholar
• Furlan AJ, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II study—A randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999; 282: 2003–11
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Ali Z, Suri MF, Kim SH, Shatla AA, Ringer AJ, et al. Intra-arterial third-generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery. 2001; 49: 41–50
   PubMed Web of Science ®Google Scholar
• Sobel BE. Intracranial bleeding fibrinolysis and anticoagulation: Causal connections and clinical implications. Circulation. 1994; 90: 2147–52
   Google Scholar
• Asahi M, Asahi K, Jung JC, del Zoppo GJ, Fini ME, Lo EH. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab. 2000; 20: 1681–9
   PubMed Web of Science ®Google Scholar
• Xue M, Del Bigio MR. Acute tissue damage after injections of thrombin and plasmin into rat striatum. Stroke. 2001; 32: 2164–9
   PubMed Web of Science ®Google Scholar
• Castellino FJ. Plasmin. Handbook of proteolytic enzymes, AJ Barrett, ND Rawlings, JF Woessner. California Academic Press, San Diego 1998; 190–9
   Google Scholar
• Pfefferkorn T, Rosenberg GA. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion. Stroke. 2003; 34: 2025–30
   PubMed Web of Science ®Google Scholar
• Lane DA, Björk I. Heparin and related polysaccharides. Advances in Experimental Medicine and Biology, DA Lane, I Björk, U Lindahl. Springer, UppsalaSweden 1992; 313: 138–142
   Google Scholar
• Rosenberg RD, Bauer KA. The heparin-antithrombin system: a natural anticoagulant mechanism. Hemostasis and thrombosis: basic principles and clinical practice, RW Colman, J Hirsh, VJ Marder, EW Salzman. Lippincott, Philadelphia 1994; 837–60
   Google Scholar
• Ende N, Auditore JV. Activation of a fibrinolytic system in a dog with mast cell tumor. Am J Physiol. 1964; 206: 567–72
   Google Scholar
• Valent P. Role of mast cells in endogeneous fibrinolysis and related (patho) physiological processes. Mast cells and basophils. London: Academic Press, G Marone, LM Lichtenstein, SJ Galli, 2000; 497–505
   Google Scholar
• Gordon JR, Galli SJ. Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biological responses. J Exp Med. 1991; 174: 103–7
   Google Scholar
• Galli SJ, Gordon JR, Wershil BK. Cytokine production by mast cells and basophils. Curr Opin Immunol. 1991; 3: 865–73
   PubMed Web of Science ®Google Scholar
• Wershil BK, Wang ZS, Gordon JR, Galli SJ. Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha. J Clin Invest. 1991; 87: 446–53
   PubMed Web of Science ®Google Scholar
• Zhang Y, Ramos BF, Jakschik BA. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science. 1992; 258: 1957–9
   PubMed Web of Science ®Google Scholar
• Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today. 1990; 11: 458–64
   PubMedGoogle Scholar
• Ehrlich, P. Beitrage zur Theorie und Praxis der histologischer Farbung. In: Thesis. Vol. Ph.D. Leipzig: University of Leipzig; 1878.
   Google Scholar
• Lupia E, Del Sorbo L, Bergerone S, Emanuelli G, Camussi G, Montrucchio G. The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils. Immunology. 2003; 109: 557–63
   Google Scholar
• Enlimomab Acute Stroke Trial Investigators. Use of anti-ICAM-1 therapy in ischemic stroke: Results of the Enlimomab Acute Stroke Trial. Neurology. 2001;57:1428–34.
   PubMed Web of Science ®Google Scholar
• Krams M, Lees K, Hacke W, Grieve A, Orgogozo J, Ford G. Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke. 2003; 34: 2543–8
   PubMed Web of Science ®Google Scholar
• Emerich DF, Dean RL, Bartus RT. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?. Exp Neurol. 2002; 173: 168–81
   PubMed Web of Science ®Google Scholar
• Strbian D, Tatlisumak T, Ramadan UA, Lindsberg PJ. Mast cell blocking reduces brain edema and hematoma volume and improves outcome after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab. 2007; 27: 795–802
   PubMed Web of Science ®Google Scholar
• Reddigari S, Silverberg M, Kaplan AP. Assembly of the human plasma kinin-forming cascade along the surface of vascular endothelial cells. Int Arch Allergy Immunol. 1995; 107: 93–4
   Google Scholar
• Dziedzic T, Bartus S, Klimkowicz A, Motyl M, Slowik A, Szczudlik A. Intracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in blood. Stroke. 2002; 33: 2334–5
   PubMed Web of Science ®Google Scholar
• Silva Y, Leira R, Tejada J, Lainez JM, Castillo J, Davalos A. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke. 2005; 36: 86–91
   PubMed Web of Science ®Google Scholar
• Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneuos intracerebral hemorrhage. N Engl J Med. 2001; 344: 1450–60
   PubMed Web of Science ®Google Scholar
• Rosand J, Eskey C, Chang Y, Gonzalez RG, Greenberg SM, Koroshetz WJ. Dynamic single-section CT demonstrates reduced cerebral blood flow in acute intracerebral hemorrhage. Cerebrovasc Dis. 2002; 14: 214–20
   PubMed Web of Science ®Google Scholar